Boston, MA (PressExposure) February 21, 2013 -- Riccardo Perfetti, Vice President of Global Medical Affairs Diabetes Division at Sanofi To Give a Keynote Presentation on "The Most Recent ADA/EASD Guidelines Are Changing the Development Strategies: A Focus Combination Therapy for the Treatment of Diabetes" at Diabetes Summit 2013 in Boston, MA on April 29-30.
Dr. Riccardo Perfetti M.D. Ph.D, is Vice President of Global Medical Affairs in the Diabetes Division at Sanofi. In his current role, Dr. Perfetti is engaged in defining the interaction between the Diabetes Division and the outside interlocutors, including academia, the key opinion leaders, the regulatory bodies; and the payors. Dr. Perfetti is also the Head of the Diabetes Medical Group which includes the top appointed medical personnel in the countries affiliate organizations. Together with the Vice President for R&D, Dr. Perfetti co-leads the Development Department which includes all clinical activities from Phase 1 to post-marketing-Phase-4 type of studies.
Diabetes Summit 2013 brings together venture capitalists, industry authoritative experts and leaders from academic institutions (Rhythm, Burrill & Co., NIH, Novo Nordisk, Johnson and Johnson, Astra Zeneca, Thermo Fisher, Merck, Mesoblast, Zafgen, Medpace, Mannkind, Metanomics, Boston University, Harvard, Arizona State, Tufts, etc.) to cover many current and relevant aspects of Diabetes.
GTC's Diabetes Summit 2013 will run concurrently with Stem Cell Summit 2013. These two Summits will provide delegates unmatched learning and networking opportunities in the following tracks, provided through our Summit Pass:
1) 6th Diabetes Drug Discovery
2) 3rd Diabetes Partnering and Deal-making
3) Stem Cell Research and Regenerative Medicine
4) Stem Cell Commercialization and Partnering
For more information, please visit http://www.gtcbio.com